Qube Research & Technologies (QRT)
TPST icon

Qube Research & Technologies (QRT)’s Tempest Therapeutics TPST Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$59 – 4117
2024
Q2 		$59 Hold
2
– – ﹤0.01% 3489
2024
Q1 		$106 Hold
2
– – ﹤0.01% 4176
2023
Q4 		$119 Hold
2
– – ﹤0.01% 4018
2023
Q3 		$8 Buy
+2
New +$19 ﹤0.01% 3944
2020
Q3 		– Sell
-54
Closed -$19K – 2110
2020
Q2 		$19K Buy
+54
New +$21.5K ﹤0.01% 1654

Other funds holding TPST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TPST Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Tempest Therapeutics (TPST) in Q3 2024, closing a stake of 2 shares — an estimated $59 sold.

Qube Research & Technologies (QRT) first reported a position in TPST in Q2 2020 and held it in 5 quarters. The position peaked at $19K in Q2 2020. 28 funds tracked by Wall St. Rank hold TPST as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Tempest Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2 Tempest Therapeutics shares in Q3 2024, an estimated $59.
  • Qube Research & Technologies (QRT) first reported a position in Tempest Therapeutics in Q2 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Tempest Therapeutics position peaked at $19K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.